STn-KLH vaccine (an epitope found among others on MUC1 that activates estrogen receptor-α function), given concurrently with endocrine therapy, offered a robust antibody response to the vaccine and an OS advantage to metastatic BC patients in a retrospective blinded review involving 1028 women (96). The gene discussed is ESR1; the disease is breast cancer.